HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy and safety of bepridil for prevention of ICD shocks in patients with Brugada syndrome and idiopathic ventricular fibrillation.

AuthorsYoshiyasu Aizawa, Hiroyuki Yamakawa, Seiji Takatsuki, Yoshinori Katsumata, Takahiko Nishiyama, Takehiro Kimura, Nobuhiro Nishiyama, Kotaro Fukumoto, Yoko Tanimoto, Kojiro Tanimoto, Hideo Mitamura, Satoshi Ogawa, Keiichi Fukuda
JournalInternational journal of cardiology (Int J Cardiol) Vol. 168 Issue 5 Pg. 5083-5 (Oct 12 2013) ISSN: 1874-1754 [Electronic] Netherlands
PMID23954005 (Publication Type: Letter)
Chemical References
  • Anti-Arrhythmia Agents
  • Bepridil
Topics
  • Adult
  • Aged
  • Anti-Arrhythmia Agents (adverse effects, therapeutic use)
  • Bepridil (adverse effects, therapeutic use)
  • Brugada Syndrome (drug therapy, epidemiology, physiopathology)
  • Cohort Studies
  • Defibrillators, Implantable (adverse effects)
  • Electric Injuries (epidemiology, physiopathology, prevention & control)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Treatment Outcome
  • Ventricular Fibrillation (drug therapy, epidemiology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: